A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.

Completed · Phase 3

Conditions studied: Hypertension

In brief

To evaluate the efficacy, safety, and toleration of eplerenone in the treatment of children aged 6 to 16 years with high blood pressure. The study will last approximately 10 weeks and about 320 patients will participate.

Key facts

Study ID

NCT00147589

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

320

Starts

2004-09-01

Expected to finish

2007-01-01

Last updated by the study team

2020-12-22

Who can join

Age: 6 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 6-16 years old male and female
• Systolic blood pressure greater than or equal to the 95th percentile for age, gender, and height, measured on at least 3 separate occasions

You may not qualify if…

• K/DOQI classification of stages of chronic kidney disease equal to or greater than 3
• Serum or whole blood potassium > 5.5 mEq/L

Where it is running

• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — Inglewood, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Augusta, Georgia, United States
• Pfizer Investigational Site — Park Ridge, Illinois, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Shreveport, Louisiana, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — Jackson, Mississippi, United States
• Pfizer Investigational Site — Tupelo, Mississippi, United States
• Pfizer Investigational Site — Livingston, New Jersey, United States
• Pfizer Investigational Site — Carrboro, North Carolina, United States
• Pfizer Investigational Site — Chapel Hill, North Carolina, United States
• Pfizer Investigational Site — Pittsboro, North Carolina, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Columbus, Ohio, United States
• Pfizer Investigational Site — Youngstown, Ohio, United States
• Pfizer Investigational Site — Tulsa, Oklahoma, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.